Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Endometrial Neoplasms 7Lymphatic Metastasis 5Uterine Cervical Neoplasms 4Urinary Bladder Neoplasms 3Breast Neoplasms 3Stomach Neoplasms 2Prostatic Neoplasms 2Ovarian Neoplasms 2Neoplasm Metastasis 2Lung Neoplasms 2Esophageal Squamous Cell Carcinoma 2Esophageal Neoplasms 2Colorectal Neoplasms 2Carcinoma, Transitional Cell 2Uterine Neoplasms 1Urologic Neoplasms 1Ureteral Neoplasms 1Thyroid cancer, follicular 1Thyroid Neoplasms 1Thyroid Carcinoma, Anaplastic 1Thyroid Cancer, Papillary 1Recurrence 1Radiation Injuries 1Prostate Adenocarcinoma 1Postoperative Complications 1Neoplastic Cells, Circulating 1Neoplasms 1Mixed Tumor, Mesodermal 1Melanoma 1Lymphedema 1

Interventions

Radiotherapy 1Paclitaxel 1Magnetic Resonance Spectroscopy 1Lymph Node Excision 1Indocyanine Green 1Ifosfamide 1Cisplatin 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Mixed Tumor, Mesodermal × Lymph Node Excision × Clear all
NCT01737619 2026-05-04

PET/CT and Lymph Node Mapping in Finding Lymph Node Metastasis in Patients With High-Risk Endometrial Cancer

M.D. Anderson Cancer Center

Phase NA Active not recruiting
101 enrolled 8 charts

Mixed Tumor, Mesodermal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡